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Abstract 13 
Background: Cutaneous leishmaniasis (CL) is the most prevalent neglected tropical disease 14 
among externally displayed people in the Middle East. In recent years, the Lebanese population 15 
has increased >30% mainly due to a mass influx of Syrian migrants, thousands of them carrying 16 
CL among other infectious diseases. Here, we revisited the current CL prevalence among 17 
refugees in Northern Lebanon. 18 
Methods: This cohort study was conducted at the Al-Bachaer Medical Center in North Lebanon 19 
between 01/2017 and 06/2017. Randomly selected, forty eight suspected CL patients were 20 
clinically diagnosed by dermatologists, and samples were obtained for microscopic examination 21 
and molecular identification by PCR-RFLP. The treatment response to antimonials was assessed 22 
at each week and was followed for up 6 months.  23 
Results: Leishmania tropica was the most predominant species (91.7%) followed by L. major 24 
(8.3%). Confirmed cases were treated with 1-2 courses of antimonials, and healing was achieved 25 
mainly after receiving a second course of treatment. Importantly, we show evidence of possible 26 
local CL transmission by indigenous sand flies in three separate patients who had no history of 27 
recent travel to Syria.  28 
Conclusions: This highlights the urgent necessity to implement preventive disease strategies to 29 
avoid further dispersion of L. tropica CL in North Lebanon. 30 
Keywords 31 
Cutaneous leishmaniasis, Glucantime, Lebanon, Leishmania tropica, PCR-RFLP, Syrian 32 
refugees.  33 
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Introduction 35 
Cutaneous leishmaniasis (CL) is the most prevalent neglected tropical disease (NTD) in 36 
the conflict zone in the Middle East, which currently affects more than hundred thousands of 37 
refugees annually.1,2 Ongoing civil war in Syria resulted in mass migration of five million 38 
Syrians to neighboring countries.3 Lebanon, situated to the west of Syria, has the highest per-39 
capita of refugees in the world (232 per 1,000 inhabitants) by hosting more than one million 40 
Syrian refugees, an enormous stress on a historically fragile country with a population of just 4 41 
million.4 As reported by Oxfam T5, the area of North Lebanon, including districts of Tripoli, 42 
Zgharta, Becharreh, Minieh-Dinieh, El-Koura hosts 283,728 Syrian refugees that counted as one 43 
third of the total T5 population with 833,728 inhabitants. While Akkar district hosts 95,403 44 
Syrian refugees counted as 33% of the total population of Akkar numbering around 293,577 45 
persons.5  46 
Historically, Lebanon has had a very low annual prevalence of CL. Only 6 CL cases were 47 
recorded in Lebanon during 2000-2012,6 in addition to few cases of visceral leishmaniasis in 48 
rural areas located at the Lebanese-Syrian borders.7 Recently, outbreaks of CL among Syrian 49 
refugees started to be reported by hospitals and primary health care centers.8 Furthermore, mass 50 
migration of Syrians fled from Aleppo and Edleb were reported several thousand cases of CL.9,10 51 
Moreover, the phlebotomine sand fly vectors Phlebotomus tobbi, Ph. syriacus, Ph. alexandri and 52 
Ph. sergenti have been identified in high-altitude mountains of Lebanon.11 Thus, the presence of 53 
local sand fly vectors and a continual influx of CL-infected refugees into other areas of Lebanon 54 
further increase the risk of disease emergence. 55 
4 
 
The clinical manifestations of CL vary widely from spontaneous self-healing ulcer to 56 
debilitating chronic or disfiguring lesions.12 The drugs used to treat CL are expensive with 57 
significant toxicity and side effects. Meglumine antimoniate (Glucantime) remains the first-line 58 
treatment for CL in most countries, including Lebanon.13 In many cases, CL ulcers develop 59 
secondary infections, which according to the World Health Organization (WHO) are first treated 60 
with a combination of antibiotics and antifugal creams followed by 1-2 courses of intralesional 61 
(or intramuscular) meglumine antimonite depending on the number, size and location of the 62 
lesions.13 The WHO has offered more than 10,000 ampoules of Glucantime for the treatment of 63 
CL in Lebanon. 64 
In this study, we report on the epidemiology of CL among refugees in North Lebanon 65 
between January to June 2017, and showed that most patients were infected with L. tropica. 66 
Furthermore, we present evidence of potential autochthonous CL transmission in North Lebanon, 67 
which highlights the need of establishing a coordinate disease control program to avoid a further 68 
CL dispersion in the region.  69 
 70 
Methods 71 
Inclusion of patients  72 
This cohort study was conducted at the Al-Bachaer Medical Center in North Lebanon 73 
between 01/2017 and 06/2017. Forty-eight CL patients were clinically diagnosed by well-trained 74 
dermatologist according to symptoms (presence of characteristic sore or ulcer lesions). Samples 75 
were taken from 18 females and 30 males, ranging in age from 1 to 60 years, with a median age 76 
of 10 years (interquartile range, 5-17 years). The majority of patients (79%) were younger than 77 
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18 years. Case record studies and information sheets were obtained for all patients and re-78 
labelled with the appropriate study code. The recorded patient information included age, sex, 79 
region of origin, date of entrance to Lebanon, address and all relevant clinical data (i.e. lesion 80 
size, number(s) and location(s) on the body, clinical features and treatment response). All data 81 
were kept in secure computer folders. 82 
Sample collection  83 
Needle aspiration was performed in each patient for microscopy analysis after Giemsa 84 
staining. Isohelix (SK-2S, UK) swab samples were taken by rubbing the ulcer approximately 20 85 
times in a clockwise direction after removing the covered crust or scabs; the surrounded area was 86 
then cleaned with 70% ethanol. All swabs were then processed for molecular diagnosis as 87 
indicated below. 88 
 89 
DNA extraction and molecular identification  90 
Total genomic DNA was extracted from all lesion swabs using Qiagen DNeasy Blood & 91 
Tissue Kit (Qiagen, USA) according to the manufacturer’s instructions. Leishmania species were 92 
identified by PCR-RFLP (Polymerase chain reaction- Restriction fragment length 93 
polymorphism) analysis of the ribosomal Internal Transcribed Spacer 1 (IST1), as described 94 
previously.14 Primers used were: LITSR (5′- CTGGATCATTTTCCGATG -3′) and L5.8 (5′- 95 
TGATACCACTTATCGCACTT -3′). The PCR mixture contained 4.0 mM MgCl2, 200 µM 96 
dNTPs, 500 nM primers, 2 U Taq polymerase (KAPA Biosystem) and 1.5 mM MgCl2. After 5 97 
minutes denaturation at 94°C, PCR was performed using 35 cycles of 30 seconds at 94°C, 30 98 
seconds at 53°C, and 60 seconds at 72°C. There was a final extension step of 72°C for 8 mins.14 99 
For swab samples negative by ITS1-PCR, DNA was extracted from smears and amplified using 100 
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the same PCR protocol.14,15 Subsequently, 10 µL of PCR product was digested with 1 unit of 101 
HaeIII digest (New England Biolabs) for 2 hours at 37°C. Restriction fragments were analysed 102 
on 2% (w/v) agarose gels using ethidium bromide. The leishmaniasis infections were identified 103 
by clinical assessment and confirmed by laboratory analysis. 104 
 105 
Drug Treatment 106 
Clinically diagnosed CL-infected patients were treated with 0.5-5ml (85 mg Sb/ml) of 107 
intralesional antimonials twice a week, for 3-4 weeks until healing was completed. Systemic 108 
administration of antimonials (20 mg Sb/kg/day for 20 consecutive days) was also used in 109 
patients presenting multiple (>5), large (>5 cm) or disfiguring lesions. Treatment failure was 110 
defined by the lack of re-epithelialization after receiving one course (12 doses) within 45 days of 111 
treatment starting.13  112 
 113 
Data and statistical analysis  114 
Statistical analyses were performed using the IBM SPSS Statistics v22.0 software. 115 
Results were presented as the median with interquartile range for quantitative variables (age) and 116 
number (percentages) for qualitative variables. The association of the variable swab sample 117 
technique along with PCR, in infected patients with suppurative lesions and dry lesions, was 118 
determined using the Fisher's exact test and differences were considered to be statistically 119 
significant at p<0.05. 120 
 121 
Results 122 
Origin and distribution of CL patients  123 
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Confirmed patients mainly originated from CL endemic and non-endemic areas of North 124 
Syria. Most of them migrated from Edleb (44%; 21/48), followed by Hama (25%; 12/48), 125 
Aleppo (17%; 8/48), Rakkah (6%; 3/48), Homos (6%; 3/48) and Tartous (2%; 1/48) (Figure 1). 126 
By the time this study was conducted, these patients were residing in North Lebanon, especially 127 
in Tripoli district (29%; 15/48) followed by Miniyeh-Dannieh (24%; 10/48) and Zgharta districts 128 
(24%; 10/48). They are localized primarily in Badawi camps and Tebbeneh region, which are 129 
one of the poorest areas of Northern Lebanon. The level of poverty in these regions is quite high, 130 
with insufficient hygiene, inadequate sanitation and infrastructure.  131 
 132 
Clinical presentations of CL-infected patients  133 
Forty-three patients developed newly active CL lesion while five had chronic lesions. 134 
The duration of the lesions prior to sampling ranged from 4 weeks to 48 months. Furthermore, 135 
the majority of the ulcers were reported to have appeared between 1 week up to 3 years after 136 
their displacement to Lebanon. A higher proportion of the patients have lesions located in the 137 
facial area (67%; 32/48), followed by the arms (31%; 15/48), legs (14.5%; 7/48), trunk (4%; 138 
2/48) and shoulder (4%; 2/48) (Figure 2). Moreover, the lesion size varied from 0.5 to 7 cm with 139 
an average mean of 1.3 cm. Nodular lesions were the most predominant clinical presentation 140 
(67%; 32/48) followed by papular (23%; 11/48) and plaque lesions (10%; 5/48), and suppuration 141 
was predominately present in nodular (66%; 21/32) and plaque forms (40%; 2/5).  142 
Interestingly, CL was also diagnosed in three patients that have settled in Lebanon for 143 
more than 32 months and with no recent history of traveling or diagnosed with CL. These 144 
individuals lived in very poor areas of Tripoli (Abou Samra-chok), Akkar and Kalamoun, which 145 
are characterized for accumulation high amount rubbish and organic matter from animals (well-146 
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known sand fly breeding sites) (Figures 1 and 3). All three patients were diagnosed by both 147 
microscopy examination and PCR, and presented ulcerative nodules bigger than 2 cm in size for 148 
at least 4 months.   149 
 150 
Microscopy and molecular identification  151 
After DNA extraction from Isohelix ulcer swab and smear aspiration, the 48 samples 152 
from CL suspect individuals were positive for Leishmania spp. by PCR. L. tropica was the most 153 
predominant species (44/48; 91.7%) followed by L. major (4/48; 8.3%). Patients infected by L. 154 
tropica originated mainly from Edleb (21/44; 48%), Hama (12/44; 27%), Aleppo (7/44; 16%), 155 
Homes (3/44; 7%), and Tartous (1/44; 2%). Whereas, Al Rakka (3/4; 75%) and Aleppo (1/4; 156 
25%) were the original cities for patients infected by L. major (Figure 1).  157 
By microscopic examination (ME), 39 samples were positive by identifying at least one 158 
Leishmania amastigote in smears. The sensitivity of ME for L. tropica was 73% (32/44) and 159 
100% (4/4) for L. major. The majority of suppurative lesions (83%; 19/23) were successfully 160 
genotyped by PCR after DNA extraction of Isohelix swabs whereas only 48% (12/25) of dry 161 
lesion swabs gave positive results. This indicates that swab sampling method along with PCR is 162 
significantly more suitable for the molecular diagnosis of suppurative lesions than dry lesions 163 
(Fisher-test=0.016).   164 
 165 
Treatment response 166 
Among the 48 confirmed CL patients, we followed the treatment response for 43 patients 167 
who developed new active lesions. Results showed that only 20 patients (46%) healed after one 168 
course of intralesional Glucantime (12 doses within 45 days), whereas, 18 (42%) and 3 (7%) of 169 
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the patients required a second and third course of Glucantime, respectively. In addition, two 170 
patients (5%) receiving systemic drug treatment were cured after one course of treatment over a 171 
period of 20 days.  172 
 173 
Discussion 174 
Dispersion of CL continues to be one of the most important health consequences of the 175 
current Syrian conflict, particularly in externally displaced Syrian migrants. In this work, we 176 
present an update of CL epidemiology in the northern districts of Lebanon, which are in 177 
geographical proximity to CL-endemic Syrian regions such as Homos, Hama and Edleb and 178 
where ca. 75% of patients included in our study originated from. The molecular analysis showed 179 
that L. tropica is the main parasite species identified in the above cities in addition to Aleppo and 180 
Tartous. Interestingly, most of the patients infected with L. major originated from Al-Raqqah, 181 
which was the capital of the so-called Islamic State terrorist group over 3 years of war. This 182 
region is not historically endemic by CL, but it became one of the most affected by this disease 183 
during the Syrian conflict.1 However, L. major is also known to be prevalent in Deir Al-Zour and 184 
Al-Hasakeh cities,16 which are located approx. 150 km from Al-Raqqah. These results support a 185 
previous report1 suggesting that a massive internal human displacement combined with 186 
ecological disruption of Ph. papatasi (L. major vector) habitats in neighbor regions may have 187 
contributed to the marked increase of CL in Al-Raqqah region. In June 2017, a new outbreak was 188 
also recorded in the western countryside of Dara’a governate, mostly in the town tell Shihab. 189 
This city had almost no incidence of CL in the past, but the number of confirmed CL cases has 190 
currently increased suggesting that sandflies vector might have been carried by families moving 191 
from the infected areas.17 In parallel, the effect of Syrian civil war on the epidemiology of CL in 192 
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other neighboring countries such as Turkey was also demonstrated in many recent studies.18,19  193 
Turkey is a CL-endemic country and it currently hosts around ~3 million Syrian refugees in the 194 
south/southeaster part of the country, leading to a large increase in the number of CL cases.18  195 
Most of the CL-infected individuals included in our study were young children (67%) 196 
presenting permanent scars, which are likely to blight their social interactions and incorporation 197 
into the Lebanese society. This creates a terrible social stigma due to the double impediment to 198 
their mental health of being both refugees and carrying CL.20 In fact, the presence of CL scars 199 
alone can cause depression, anxiety and an overall decrease in the quality of life of infected 200 
individuals.21 These psychological and socio-economic impacts will be substantially more 201 
noticeable in refugee settings due to the conditions of some of these places. Therefore, future 202 
studies aiming to assess the mental health burden of the CL patients in refugee settings are 203 
needed in order to formulate recommendations about how simple interventions to address mental 204 
health problems can be introduced.  205 
 During the first four years of the Syrian conflict, Lebanon maintained open borders with 206 
Syria. While there are no formal refugee camps for Syrians were established in Lebanon, roughly 207 
18% of Syrians live in informal tented settlements around the country. The others are left to 208 
dwell in villages and cities without any centralized or regional plan. They are localized in the 209 
Northern districts, one of the most deprived regions with severe poverty levels and a high 210 
number of refugee migrants. This implies that approximately half of the population of Lebanon’s 211 
Northern districts (T5) are refugees living below the poverty line.22 The huge influx of refugees 212 
into these regions has put a strain on the scanty local resources. It has increased the depletion of 213 
water, sanitation and hygiene, the lack of basic infrastructure and the accumulation of rubbish, 214 
which collectively promote the perfect breeding sites for Ph. sergenti vector.5 Thus, the 215 
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combination of this suitable environment, the presence of sand fly vectors and refugee migrants 216 
presenting either active or inactive (asymptomatic carriers) CL, exhibit a higher threat for the re-217 
emergence of this disease in some areas in Lebanon. Furthermore, in our study, a possible local 218 
CL transmission by indigenous sandflies was observed in the three separate cases, although we 219 
cannot rule out that these patients were asymptomatic carriers before they migrated to Lebanon. 220 
As the last entomological data concerning sandflies in Lebanon is related to a phlebotomine sand 221 
fly collection realized in 1995,11 the characterization of medically important local sand fly 222 
species, including bloodmeal preferences and vectorial capacity, is a high priority to update 223 
information on the current distribution and dispersion of sand fly fauna in North Lebanon and to 224 
prevent future local outbreaks. In addition, xenodiagnosis of wild-caught sand flies will reveal 225 
the possible existence of autochthonous transmission and the necessity to implement a local CL 226 
preventive control strategy. Although the number of identified local cases is relatively low in our 227 
study, other similar cases could be present but either underestimated, misdiagnosed or 228 
underreported. For instance, studies showed that CL incidence in Jordan may be underestimated 229 
by 40- to 47- fold in national surveillance data.23 No empirical assessments of CL underreporting 230 
are available from the Lebanese official surveillance data.  231 
Patients treated in Lebanon receive 1-2 courses of intralesional (or intramuscular in case 232 
of multiple lesions), highly toxic and painful pentavalent antimonials according to current CL 233 
treatment regimens. This creates a problem because, as our data show, most of the confirmed CL 234 
cases were infected with L. tropica, which is naturally more resistant to Glucantime24 and in fact 235 
most of the cases needed a second (and sometimes a third) course of treatment to achieve clinical 236 
cure (49%). The four cases infected by L. major were healed with a second course of anti-237 
leishmanial treatment. However, we cannot conclude about species treatment response due to the 238 
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low number of L. major isolates. The variations to antimonial treatment may either be influenced 239 
by different factors such as parasite species, the presence of secondary infections within/around 240 
the lesion and the spread of drug-resistant parasites.24-25  241 
As for the prevalence of visceral leishmaniasis (VL) among Syrian migrants, some cases 242 
were recorded at the coast Syrian borders.7 Ph. syriacus and domestic dogs (Canis lupus 243 
familiaris) were identified as the main implicated VL vector and reservoir, respectively.26 244 
Unfortunately, the burden of Syrian crisis on VL and their reservoir in Lebanon has not been yet 245 
determined. During 2014–2017, five Syrian refugee children died of VL caused by L. infantum 246 
because of a late diagnosis and lack of awareness of this disease in Lebanon.27 Recently, four 247 
other cases of VL from Syrian refugees were diagnosed in the Lebanese hospitals and were 248 
treated by Amphotericin B.28 The risk of introduction of L. major and/or L. tropica besides L. 249 
infantum is highly regarded with the presence of their correspondent reservoirs and vectors. Cats 250 
(Felis catus) were identified as susceptible reservoir for L. tropica and L. major in MENA 251 
region.29 On the other hand, humans are considered the main reservoir for the anthroponotic 252 
transmission of L. tropica,29 and Ph. tobbi, Ph. sergenti, Ph. pappatasi, Ph. syriacus and Ph. 253 
alexandri sand fly species have been already identified in the Lebanese mountains.11 254 
Collectively, this suggests that Lebanon currently presents all the conditions for the 255 
autochthonous transmission of both forms of Leishmaniasis if not preventive disease control 256 
measures are put in place by local health authorities. 257 
While the conflict in Syria approaches its ninth year, the military conflict has stopped in 258 
some cities that pushed thousands of refugees to return amid fresh hope for last ceasefires. 259 
According to the UNHCR, more than 440,000 internally displaced Syrian and about 22,000 of 260 
whose fled abroad had come back to cities, which are partly or wholly controlled by the Syrian 261 
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government, including Damascus, Aleppo, Hama and Homos.30 This recent situation is highly 262 
dangerous because of the risks of returning to a destroyed and unsafe country lacking 263 
international support. The deterioration of basic infrastructure, buildings and hospitals, the lack 264 
of access to the primary health care and the increasing rate of many infectious diseases such as 265 
leishmaniasis will introduce a high risk of morbidity for persons coming back. Sandflies vector 266 
will be at high density in these adequate regions for multiplication and without control measures. 267 
As a result, people can contract leishmaniasis and then become reservoirs that could contribute 268 
with disease spreading on a large scale, especially with the non-sustainability of this return 269 
without the social determinants of global health such as employment opportunities, adequate 270 
food and water and health care infrastructure. 271 
In Summary, L. tropica is the most predominant species among refugees in North 272 
Lebanon. The majority of patients needed at least two courses of glucantime to achieved cured. 273 
The identification of a possible local transmission in Lebanon highlights the urgent necessity to 274 
perform entomological studies to characterize the local sand fly vectors. This will help develop 275 
targeted vector control strategies in CL-endemic areas to specifically prevent local L. tropica 276 
transmission. 277 
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 393 
Figure 1. Geographic distribution of Cutaneous Leishmaniasis (CL) cases identified among 394 
Syrian refugees in Lebanon (Small box) and their relative region of origin (Round dots). 395 
The majority of patients are coming from the northern Syrian regions especially Edleb (44%) and 396 
Hama (25%). Infected Syrian refugees are migrated mainly to Tripoli (31%). L. tropica (Red 397 
dots) is the main genotype identified among CL cases followed by L. major (Yellow dots). The 398 
green strikes indicated the location of the three probable local transmission CL cases in North 399 
Lebanon.  400 
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Figure 2. Patterns of cutaneous leishmaniasis among Syrian refugees in Lebanon, 2017. A 406 
and B, Disfiguring facial lesions. C, Satellite lesions on the outer edge of CL primary lesion. 407 
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Figure 3. Unsanitary living conditions where CL patients live. Accumulated rubbish and 412 
presence of animals create perfect sand fly habitats and promote local disease transmission. 413 
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